Citius Pharmaceuticals CTXR Cash Flow Statement (2010-2026)

NASDAQ CTXR
$0.60 -0.04 (-5.91%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-15.01M-5.13M-9.23M-7.56M-8.86M-7.41M-3.59M-10.53M-8.48M-9.94M-9.23M-8.54M-10.57M-11.08M-10.28M-11.51M-9.20M-8.74M-9.39M-28.11M
Depreciation and Depletion (Quarter)
456.00731.00730.00731.00731.00731.00730.00731.00629.00578.00578.00579.00275.00
Share-based Compensation (Quarter)
0.37M-0.93M0.90M1.02M1.00M-1.36M1.20M1.17M1.17M3.08M0.08M3.08M3.06M-8.91M2.52M2.70M3.06M2.89M4.28M3.79M
Deferred Taxes (Quarter)
0.14M0.14M0.14M0.14M0.14M0.14M0.14M0.14M0.26M0.26M0.26M0.26M0.26M-0.23M
Change in Interest Receivables (Quarter)
0.10M-0.33M1.44M-0.48M-0.48M-0.34M1.08M-0.58M-0.55M
Cash from Operations (Quarter)
-4.82M-5.59M-4.65M-9.67M-7.71M-6.33M-4.82M-7.85M-9.58M-6.80M-6.14M-7.79M-8.37M-5.91M-4.73M-4.54M-5.41M-11.88M-13.01M-1.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.04M0.04M0.04M
Amortization of Deferred Charges (Quarter)
0.04M0.04M0.04M0.04M0.04M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.04M0.06M
Depreciation & Amortization (CF) (Quarter)
456.00731.00730.00731.00731.00731.00730.00731.00629.00578.00578.00579.00275.00
Change in Working Capital
Change in Inventory (Quarter)
6.11M0.96M1.87M3.71M0.35M0.02M
Change in Account Payables (Quarter)
0.22M-0.08M0.51M-0.08M-0.01M-0.53M0.37M1.19M0.35M-0.15M-0.28M0.02M-1.01M3.26M2.44M2.00M0.73M3.60M-2.67M-1.57M
Change in Accured Expenses (Quarter)
0.13M0.26M2.51M-1.80M-0.04M0.10M-0.71M-0.02M0.22M0.91M0.27M-0.60M0.40M-0.00M6.23M2.54M-0.26M-4.33M-0.20M0.51M
Other Working Capital Changes (Quarter)
-0.04M-0.04M-0.04M-0.04M-0.04M-0.05M-0.05M-0.05M-0.05M-0.05M-0.05M-0.05M-0.05M-0.06M-0.06M-0.06M-0.05M-0.07M0.02M-0.02M
Investing Activities
Capital Expenditures (Quarter)
39.99M
Cash from Investing Activities (Quarter)
-40.00M-4.40M-0.60M
Financing Activities
Other financing activities (Quarter)
-70.90M18.37M13.77M0.08M2.57M3.47M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
0.17M
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
1.90M2.00M9.32M3.68M13.31M6.06M6.18M6.20M13.31M7.65M17.12M9.19M9.78M0.50M5.14M5.55M11.50M11.32M
Net Equity Issued and Repurchased (Quarter)
0.08M2.57M3.47M10.47M15.79M20.88M-0.06M
Misc.
Cash from Financing Activities (Quarter)
16.80M13.80M-687.00-3.75M2.57M3.47M11.47M15.79M20.88M-1.23M
Change in Cash (Quarter)
11.97M-45.59M-4.65M-9.67M-7.71M-6.33M-4.82M-7.82M4.22M-6.80M-6.14M-7.79M5.35M-14.66M-2.15M-1.07M6.06M-1.84M3.47M-3.13M
Free Cash Flow (Quarter)
-4.82M-45.58M-4.65M-9.67M-7.71M-6.33M-4.82M-7.85M-9.58M-6.80M-6.14M-7.79M-8.37M-5.91M-4.73M-4.54M-5.41M-11.88M-13.01M-1.30M
Net Cash Flow (Quarter)
11.97M-45.59M-4.65M-9.67M-7.71M-6.33M-4.82M-7.85M4.22M-6.80M-6.14M-7.79M-8.37M-9.66M-2.15M-1.07M6.06M3.91M3.47M-3.13M